Needle inspection system offers greater security

Published: 4-Feb-2010
Packaging

Seidenader Maschinenbau, a German supplier of automatic inspection machines for the pharmaceutical industry, has developed a method of verifying pierced needle shields inline and at full production speeds of up to 600 syringes/min.

Seidenader Maschinenbau, a German supplier of automatic inspection machines for the pharmaceutical industry, has developed a method of verifying pierced needle shields inline and at full production speeds of up to 600 syringes/min.

If the needles in pre-filled syringes penetrate the needle shield, they can put the sterility of both needle and syringe at risk, as well as endanger medical staff. Seidenader claims a pierced needle shield cannot be verified reliably by vision systems and even less by operators.

Applying high voltage to the lower section of the syringe - using the conductivity of the protruding needle - allows any defects to be detected with high reliability, the company says. Tests have shown that even defects hidden by rigid plastic shields (RNS) can be detected.

The inspection station can be integrated in a star wheel on Seidenader's standard VI-S inspection machine. Any syringes with defects are separated in a dedicated reject channel.




  • Companies:
  • Seidenader Group
See more

You may also like

Packaging

HVLD SOLO offers high voltage leak detection as a standalone solution

Read more
Offers efficient 360° inspection in a single machine

Trending Articles

  1. AstraZeneca to stop production of Pulmicort pMDI Agreements with SkyePharma expected to be terminated
  2. Knowledge and adaptability drive successful pharmaceutical outsourcing partnerships Third-party contract manufacturers and packers play an increasingly prominent role in the pharmaceutical sector, helping companies to both navigate the complexities of the market and capitalise on new opportunities
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Prefilled syringes: glass or polymer? Prefilled syringes come in many varieties with the most fundamental difference being the material they are made of – glass or polymer. Manufacturer Schott considers how to make the right choice
  4. Understanding the real risks of packaging When it comes to GMP production, specifying the type of packaging to be taken into the cleanroom is an important consideration. Dr Christoph Strubl, Managing Director of packaging company STRUBL, discusses the need for specialised cleanroom packaging
  5. Schott Pharma AG and Co. KGaA Advanced Drug Containment and Delivery Solutions from SCHOTT Pharma

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Packaging

HVLD SOLO offers high voltage leak detection as a standalone solution

Offers efficient 360° inspection in a single machine
Packaging

Seidenader takes new approach to cytotoxic product inspection

Also offers HVLD machine that checks for leaking parenteral containers
Packaging

Körber acquires Seidenader Maschinenbau

Aims to expand pharmaceutical packaging systems division
Packaging

Locate, read and verify 2D codes

Seidenader SV360 offers all-round bottle check
Manufacturing

Leybold launches Duradry vacuum pump for harsh processes

Advanced technology designed for reliability and efficiency
Packaging

How pharma packaging manufacturers role is evolving: the case of extractables testing

As the pharmaceutical industry continues to grow and evolve, extractables testing is a critical component of the pharmaceutical industry's efforts to prioritise quality and safety, ensuring one of the key functions pharma containers are designed for, says Anna Malori, Head of Product Management at Bormioli Pharma
Packaging

Dual-chamber packaging systems as a simplification factor in the supply chain

Dual-chamber packaging solutions could represent a new frontier also to package parenteral drugs, simplifying the supply chain through reconstitution, potentially making logistics more flexible and efficient, says Cecilia Bassi, Product Manager at Bormioli Pharma
Subscribe now